Top Markets
Coin of the day
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336
Classificação em ações #3340
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Preço da ação
$6.23
Valor de mercado
$5.58B
Variação (1 dia)
-1.10%
Variação (1 ano)
25.53%
País
CN
Negociar Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Categoria

Histórico de preços das ações de Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Preço de fecho mais alto: $6.78 em 2026-08-01

Preço de fecho mais baixo: $4.81 em 2020-07-01
Histórico de preços das ações da Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd de 2020 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 5.67%
2025 188.76%
2024 -5.91%
2023 62.34%
2022 -30.84%
2021 -25.95%
2020 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$772.27 7.33%
CH